GLP-1 Market Size, Key Players, and the Race to Solve Compliance
Oral formulations may solve the compliance crisis that injections cannot.
Leila Nair
Features Editor
Leila Nair
Leila Nair is a features editor at Pathway in Peptides covering glp-1 biology. Based in Amsterdam, Leila has written for Pathway in Peptides since 2022.
1 story · Amsterdam